Sinovac Biotech Ltd. annual gross profit 2016-2022
In 2022, Sinovac Biotech Ltd., one of China's major vaccine producers, reported an annual gross profit of 808 million U.S. dollars. Compared to Sinovac's annual gross profit of around 200 million U.S. dollars before the COVID-19 pandemic, the figure skyrocketed by almost 85 times between 2019 and 2021, thanks to the substantial demand for the company's CoronaVac vaccine.